AI Governance in Healthcare

Set standards, assign responsibility and define how clinicians will review AI before it affects patient care.

AI governance in healthcare — clinician reviewing AI-assisted data on a mobile device

Operating model

Govern the clinical decision, not the brand name

The same foundation model can create very different risks depending on the use case, patient population, data, interface, and human workflow. Classify the use, document the evidence, and scale controls with potential harm.

1. Define

Write the intended use, excluded uses, users, affected population, decision impact, data boundaries, and accountable owner.

2. Validate

Test realistic cases, failure modes, subgroup performance, privacy, security, usability, and escalation behavior in the local context.

3. Deploy

Use role based access, clear disclosures, human review, staff training, fallback procedures, and logged release approval.

4. Monitor

Track outcomes, overrides, near misses, complaints, drift, inequities, vendor changes, and whether the tool still delivers net benefit.

Accountability that can stop the system

Executive owner

Accepts business and organizational risk and funds remediation.

Clinical owner

Owns intended use, workflow fit, clinical evidence, and patient safety thresholds.

Independent review

Challenges assumptions and reviews safety, security, privacy, equity, legal, and patient impact evidence.

Frontline users

Receive training, understand limits, report incidents, and retain authority to disregard unsafe outputs.

Start with the use that carries the greatest risk

Start with one real workflow, one accountable owner, measurable patient and operational outcomes, and a clear stop rule.

Discuss your governance needs →

Operational standard

Governance that follows the full AI lifecycle

Govern each use according to its consequences. The same foundation model can be low risk in administrative drafting and high risk when it influences diagnosis, treatment, access or resource allocation.

Tier 1 · Minimal consequence

Brainstorming, formatting, or public information tasks with no patient data and no clinical reliance.

Controls: acceptable use rules, basic literacy, and prohibited data guidance.

Tier 2 · Operational support

Drafting, summarization, scheduling, or workflow support that may affect staff or patients indirectly.

Controls: sampled review, privacy assessment, accuracy testing, and named owner.

Tier 3 · Clinical influence

Outputs that may shape diagnosis, treatment, triage, documentation, or patient communication.

Controls: local validation, subgroup testing, qualified review, monitoring, incident response, and change control.

Tier 4 · High consequence or autonomous

Systems that can materially affect care or access without timely, meaningful human intervention.

Controls: executive approval, regulatory/legal review, prospective evaluation, independent challenge, fail safe design, and a tested shutdown path.

Eight gates from idea to retirement

  1. Inventory: name the owner, intended use, users, affected people, model, vendor, data, and dependencies.
  2. Classify: assign risk from the actual consequence and level of autonomy.
  3. Evaluate evidence: separate vendor claims, peer reviewed studies, regulatory review, and local results.
  4. Validate locally: test realistic workflows, failure modes, accessibility, and performance across relevant groups.
  5. Authorize: document residual risks, accountable approvers, permitted uses, and prohibited uses.
  6. Deploy safely: train users, disclose limitations, define escalation, and preserve human authority.
  7. Monitor: track outcomes, overrides, drift, inequity, privacy/security events, complaints, and workflow burden.
  8. Change or retire: review model and workflow changes again; pause when thresholds fail; preserve records.

Minimum evidence profile

Every governed system should publish or maintain: intended use; excluded uses; model and version; data provenance; validation population; primary endpoints; subgroup results; known limitations; human oversight design; privacy/security controls; monitoring thresholds; incidents and corrections; owner; and next review date.

Important: an evidence profile is not a “safe” badge or certification. Compliance and regulatory status depend on the specific product, intended use, jurisdiction, and deployment.

Built to complement NIST AI RMF, WHO guidance on AI for health, and FDA lifecycle resources. Organizations must obtain jurisdiction specific clinical, legal, privacy, security, and regulatory review.

Reviewed September 28, 2026.